Skip to main content

LA County Imposes Ban On Roundup Weedkiller

LA County Imposes Ban On Roundup Weedkiller

LA County Imposes Ban On Roundup Weedkiller

Introduction

Los Angeles County is the latest to issue a ban on the infamous glyphosate-based weed killer, Roundup after a San Francisco federal jury ruled in the first phase of the bellwether trial that glyphosate exposure was a substantial reason for a California man, Edwin Hardeman's cancer.

The Los Angeles County Board of Supervisors, on Tuesday, March 19, instructed all its departments to stop using the weed killer, which has been in the headlines for being carcinogenic. Though the board did not give out its opinion on the recent court verdicts, Supervisor Kathryn Barger said the ban on glyphosate-containing herbicides would remain until public health, and environmental professionals can develop a safer alternative for Roundup to be used in L.A. County properties. The supervisory board asked the Department of Public Works to look for better substitutes and provide a report with recommendations within 30 days. While the outcome of the second phase of the bellwether trial involving Hardeman’s claims is still awaited, Bayer, which took over Monsanto in 2018, maintained that the product is safe to use and non-carcinogenic.

All product liability lawsuits filed against Monsanto over cancer concerns are consolidated into multidistrict litigation (MDL No. 2741; In re: Roundup Products Liability Litigation) before Judge Vince Chhabria in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!